Over
Dr Mubarak Almansour is a highly qualified Consultant Medical Oncologist and Associate Professor, recognised for their expertise in the diagnosis and management of complex cancer cases. With a patient-centred approach to care, Dr Almansour combines clinical excellence with a strong academic background, ensuring that patients receive treatment based on the latest medical evidence. They are dedicated to providing comprehensive oncology care, guiding patients through their treatment journeys with compassion and professional rigour.
Dr Almansour’s extensive medical training was completed at world-renowned institutions in North America. After obtaining their medical degree from King Abdulaziz University, they pursued postgraduate training at the University of British Columbia in Canada. There, they completed a residency in Internal Medicine followed by two specialised fellowships at the British Columbia Cancer Agency: one in Medical Oncology and a second sub-specialty fellowship dedicated to Lymphoma. They hold quadruple board certifications, having achieved the American Board and Canadian Board certifications in both Internal Medicine and Medical Oncology.
In addition to their clinical practice, Dr Almansour is an active leader in the medical community and a key contributor to oncology research. They have played a pivotal role in establishing international conferences and serve on scientific committees dedicated to advancing cancer treatment. Their clinical focus encompasses a broad range of adult malignancies, with specific sub-specialty interest in lymphoid malignancies and genitourinary tumours.
Dr Almansour’s extensive medical training was completed at world-renowned institutions in North America. After obtaining their medical degree from King Abdulaziz University, they pursued postgraduate training at the University of British Columbia in Canada. There, they completed a residency in Internal Medicine followed by two specialised fellowships at the British Columbia Cancer Agency: one in Medical Oncology and a second sub-specialty fellowship dedicated to Lymphoma. They hold quadruple board certifications, having achieved the American Board and Canadian Board certifications in both Internal Medicine and Medical Oncology.
In addition to their clinical practice, Dr Almansour is an active leader in the medical community and a key contributor to oncology research. They have played a pivotal role in establishing international conferences and serve on scientific committees dedicated to advancing cancer treatment. Their clinical focus encompasses a broad range of adult malignancies, with specific sub-specialty interest in lymphoid malignancies and genitourinary tumours.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mubarak Almansour
Opleiding & training
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Oncologie
-
2021–2022 Fellowship · Subspecialty training
Carrière & aanstellingen
-
2021-09–2022-08 Junior consultant
Vergunningen & verzekering
Medische licenties
SA — Organización Médica Colegial de España (OMC)
Boardcertificeringen
European Board of Oncologie
Beroepsaansprakelijkheidsverzekering:
Generali Healthcare · 3,000,000 EUR dekking · No claims on file
Uitgevoerde procedures
| Procedure | Code | Levenslang aantal |
|---|---|---|
| GP consultation | 99213 | 1,636 |
| Annual physical exam | 99395 | 1,442 |
| Vaccination administration | 90471 | 1,370 |
| Minor procedure (skin) | 17110 | 1,605 |
Diensten & prijzen
| Dienst | Duur | Modaliteit | Prijs |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 720.00 EUR |
Praktijk, team & in praktijk
Video's
Onderzoek & publicaties
h-index: 17 · i10: 10
-
European registry analysis of Oncologie outcomes
DOI: 10.6789/euroclin.2025.0 · PMID: 32497645 · geciteerd door 84
-
Outcomes of Oncologie in adults — a multi-centre cohort
DOI: 10.2529/euroclin.2024.1 · PMID: 37582222 · geciteerd door 6
-
European registry analysis of Oncologie outcomes
DOI: 10.7214/euroclin.2023.2 · PMID: 36115057 · geciteerd door 144
-
Outcomes of Oncologie in adults — a multi-centre cohort
DOI: 10.5013/euroclin.2022.3 · PMID: 31578989 · geciteerd door 42
Uitgenodigde lezingen
- Practical updates in Oncologie European Annual Congress (Oncologie) · Vienna · 2024 · invited
- Single-centre experience in Oncologie National Society Meeting · Riyadh · 2023 · oral abstract
Onderscheidingen & lidmaatschappen
Onderscheidingen
- 🏆 Top-rated Oncologie — Riyadh · EuroClinics Patient Choice · 2025 · regional
Lidmaatschappen
- WONCA Europe — Family Doctors — Member · Sinds 2022
- national college of family doctors — Member · Sinds 2022
- European Union of Medical Specialists (UEMS) — Member · Sinds 2022
Artikelen van deze arts
- Patient education Patient guide to Oncologie
- Awareness When should you see a oncologie?
Voor internationale patiënten
- Coördinator
- Patient liaison · mubarak.almansour@euroclinics.example
Locatie
1 tagPatiëntbeoordelingen
Deel uw ervaring — help andere patiënten de juiste arts te vinden. Schrijf een recensie →
Recente recensies
-
★★★★★ ✓ Geverifieerd Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Geverifieerd Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Geverifieerd Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.